Day One Biopharmaceuticals, Inc. Balance Sheet
DAWN / Health Care|7 years of annual SEC 10-K data (FY2019-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 7 fiscal years. All figures from audited SEC 10-K filings.
Day One Biopharmaceuticals, Inc. had $508M in total assets and $441M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $197.1M | $125.0M | $230.8M | $85.3M | $284.3M | $43.7M | $27.3M |
| Inventory | $6.3M | $3.3M | $0 | - | - | - | - |
| Current Assets | $485.1M | $562.3M | $375.3M | $347.9M | $289.4M | $45.1M | - |
| PP&E (Net) | $2.1M | $2.3M | $208.0K | $20.0K | $57.0K | $77.0K | - |
| Total Assets | $507.8M | $582.8M | $376.0M | $349.1M | $289.8M | $45.7M | - |
| Current Liabilities | $60.5M | $73.5M | $29.5M | $16.6M | $8.7M | $2.0M | - |
| Shareholders' Equity | $441.2M | $502.8M | $346.5M | $332.0M | $281.1M | -$54.2M | -$10.7M |